Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration

FEBS Lett. 2009 Sep 17;583(18):3027-32. doi: 10.1016/j.febslet.2009.08.012. Epub 2009 Aug 15.

Abstract

We previously showed that lumican decreases melanoma progression. The aim of the present study was to determine the active sequence of the lumican core protein responsible for the inhibition of melanoma cell migration. Using different recombinant and synthetic peptides derived from lumican, we localized an active site in the leucine-rich repeat 9 domain of the lumican core protein. We propose the name lumcorin (fragment of lumican core protein) for the active peptide derived from this site. Lumcorin was able to inhibit melanoma cell migration in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Catalytic Domain
  • Cell Line, Tumor
  • Cell Movement / drug effects*
  • Cell Survival / drug effects
  • Chondroitin Sulfate Proteoglycans / chemistry*
  • Chondroitin Sulfate Proteoglycans / pharmacology*
  • Chondroitin Sulfate Proteoglycans / therapeutic use
  • Humans
  • Keratan Sulfate / chemistry*
  • Keratan Sulfate / therapeutic use
  • Lumican
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Peptide Fragments / pharmacology*
  • Peptide Fragments / therapeutic use

Substances

  • Chondroitin Sulfate Proteoglycans
  • LUM protein, human
  • Lumican
  • Peptide Fragments
  • lumcorin
  • Keratan Sulfate